Major drugmakers Roche, AstraZeneca, and Johnson & Johnson plan to invest billions to expand drug manufacturing in the United States.

Roche Group AG’s RHHBY obesity drug push faces stiff competition after Genentech, a unit of Roche, reported Phase 2 results showing up to 10.7% weight loss—below expectations and lagging leading ...

Roche eyes a significant share in the weight loss market, competing against Novo Nordisk. Aspen Pharmacare anticipates a ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: The logo of Swiss drugmaker Novartis is seen at the company's new cell and gene therapy factory in Stein, Switzerland, ...

ZURICH, Dec 18 (Reuters) - Swiss pharma giants Novartis and Roche on Thursday backed U.S. efforts to lower the cost of drugs and are working with the ‌Trump administration towards that goal following ...